Reported Jun 29, 2022 · Terminated
Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only,…
Mayne Pharma Inc.
Moderate riskThis product could cause temporary or reversible health problems — stop using it.What you should do
Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.
Firm contact: Mayne Pharma Inc · 1240 Sugg Pkwy · Greenville, NC · 27834-9006
Is this the product you have?
- Clonidine Transdermal System, USP 0.3 mg/day, 4 Patches (NDC 51862-455-01) per Carton (51862-455-04), Rx only
- Manufactured forMayne Pharma Greenville, NC 27834
- Lot codes and dates
- Lot41179A Exp. Jan 2023
- Amount recalled
- 1440 cartons
Where it was sold
- Nationwide
Why it was recalled
Defective Delivery System: Out of specification for release liner removal force results at the 3-month CRT stability timepoint.
This product could cause temporary or reversible health problems — stop using it.
Want the full recall guide?
The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.
Free recall alerts
Get alerted about new Mayne Pharma Inc. recalls
One email when a matching recall is published. No account, no cost, unsubscribe in one click.
We email you about recalls and nothing else. Every send has a one-click unsubscribe, and you can change your preferences any time without an account.